Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands
Open in viewer
Van De Ven, Liesbeth I.
Overbeek, Jetty A.Show all
- Journal Article
Open in viewer
Rights / licenseCreative Commons Attribution-NonCommercial 4.0 International
Summary This is the first study to examine the association between antidepressant and benzodiazepine use following a MOF and risk of subsequent fracture in those 65+. Using national data, drug use following MOF showed that the 1-year fully adjusted risk of subsequent MOF in those on antidepressants was more than doubled. Introduction We evaluated the association between the use of antidepressants or benzodiazepines and the risk of a subsequent major osteoporotic fracture. Methods A cohort study was performed using the Dutch PHARMO Database Network. Between 2002 and 2011, a total of 4854 patients sustained a first major osteoporotic fracture after the age of 65 years, of which 1766 sustained a hip fracture. Incidence rates and adjusted hazard ratios were calculated using Cox proportional hazards models. Results Within 1 year following a major osteoporotic fracture, 15% (95% CI 13.7–15.7) and 31% (95% CI 30.1–32.8) of patients were dispensed an antidepressant or benzodiazepine, respectively. Current use of antidepressants in the first year following a major osteoporotic fracture was associated with subsequent fracture (adjusted HR 2.17 (95% CI 1.37–3.43)). Recent and past use of antidepressants were also associated with an increased risk of subsequent fracture. When the complete follow-up period was included, only the current use of antidepressants was associated with subsequent fracture following a major osteoporotic fracture (adjusted HR 1.48; 95% CI 1.06–2.06). Current benzodiazepine use was not associated with an increased risk of fracture within 1 year following a major osteoporotic fracture (adjusted HR 1.18; 95% CI 0.76–1.81) or during the complete follow-up period (adjusted HR 1.18; 95% CI 0.90–1.55). Conclusion This study provides evidence that antidepressants should be used with caution following a major osteoporotic fracture. It provides needed insights that can be used to inform clinicians when assessing subsequent fracture risk in patients Show more
Journal / seriesOsteoporosis International
Pages / Article No.
SubjectAntidepressants; Benzodiazepines; Hip fracture; Major osteoporotic fracture; Subsequent fracture
Organisational unit09633 - Burden, Andrea / Burden, Andrea
MoreShow all metadata